Blue Crest Capital Management LTD Novartis Ag Transaction History

Blue Crest Capital Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $233,740 - $287,680	-3,100 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $74,717 - $85,460	-992 Reduced 24.24%	3,100 $298,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $26,222 - $29,199	356 Added 9.53%	4,092 $351,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $294,469 - $340,614	-4,399 Reduced 54.07%	3,736 $322,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $528,042 - $596,783	8,135 New	8,135 $615,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.